Topoisomerase inhibitor induced dephosphorylation of H1 and H3 histones as a consequence of cell cycle arrest

Journal of Cellular Biochemistry

Volumn 95, Issue 6, 2005, Pages 1235-1247

  Happel, Nicole ^a,b   Sommer, Arne ^a   Hänecke, Kristina ^a   Albig, Werner ^a   Doenecke, Detlef ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Institute for Biochemistry and Molecular Cell Biology   (Germany)

Author keywords

Apoptosis; Capillary zone electrophoresis; Cell cycle; Histone; Phosphorylation; Topoisomerase inhibitor

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; HISTONE H1; HISTONE H3;

APOPTOSIS; ARTICLE; CELL CYCLE; CHEMICAL REACTION KINETICS; CHROMATIN STRUCTURE; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

CELL CYCLE; CELL LINE, TUMOR; DNA TOPOISOMERASES; ENZYME INHIBITORS; HISTONES; HUMANS; PHOSPHORYLATION;

EID: 26444570961     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20494     Document Type: Article

References (51)

1. Ajiro K. 2000. Histone H2B phosphorylation in mammalian apoptotic cells. An association with DNA fragmentation. J Biol Chem 275:439-443.
2. Boggs BA, Allis CD, Chinault AC. 2000. Immunofluorescent studies of human chromosomes with antibodies against phosphorylated H1 histone. Chromosoma 108:485-490.
3. Bradbury EM, Inglis RJ, Matthews HR, Sarner N. 1973. Phosphorylation of very-lysine-rich histone in Physarum polycephalum. Correlation with chromosome condensation. Eur J Biochem 33:131-139.
4. Bradbury EM, Inglis RJ, Matthews HR. 1974. Control of cell division by very lysine rich histone (F1) phosphorylation. Nature 247:257-261.
5. Cheng CH, Kuchta RD. 1993. DNA polymerase epsilon: Aphidicolin inhibition and the relationship between polymerase and exonuclease activity. Biochemistry 32:8568-8574.
6. Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, Mizzen CA, Beeser A, Etkin LD, Chernoff J, Earnshaw WC, Allis CD. 2003. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113:507-517.
7. Del Bino G, Skierski JS, Darzynkiewicz Z. 1990. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells. Cancer Res 50:5746-5750.
8. Del Bino G, Skierski JS, Darzynkiewicz Z. 1991. The concentration- dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195:485-491.
9. Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E. 1995. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia 9:1013-1024.
10. Endresen PC, Prytz PS, Aarbakke J. 1995. A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA. Cytometry 20:162-171.
11. Enomoto R, Koyamazaki R, Maruta Y, Tanaka M, Takuma K, Mori K, Lee E. 2001. Phosphorylation of histones triggers DNA fragmentation in thymocyte undergoing apoptosis induced by protein phosphatase inhibitors. Mol Cell Biol Res Commun 4:276-281.
12. Felsenfeld G, Groudine M. 2003. Controlling the double helix. Nature 421:448-453.
13. Goto H, Yasui Y, Nigg EA, Inagaki M. 2002. Aurora-B phosphorylates histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 7:11-17.
14. Grant PA. 2001. A tale of histone modifications. Genome Biol 2:REVIEWS0003.
15. Hendzel MJ, Nishioka WK, Raymond Y, Allis CD, Bazett-Jones DP, Th'ng JP. 1998. Chromatin condensation is not associated with apoptosis. J Biol Chem 273:24470-24478.
16. Hohmann P, Tobey RA, Gurley LR. 1976. Phosphorylation of distinct regions of f1 histone. Relationship to the cell cycle. J Biol Chem 251:3685-3692.
17. Horn PJ, Peterson CL. 2002. Chromatin higher order folding: Wrapping up transcription. Science 297:1824-1827.
18. Huang X, Traganos F, Darzynkiewicz Z. 2003. DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis. Cell Cycle 2:614-619.
19. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293:1074-1080.
20. Jordan MA, Thrower D, Wilson L. 1992. Effects of vinblastine, podophyllotoxin, and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci 102(Pt 3):401-416.
21. Kantarjian H. 1999. New developments in the treatment of acute myeloid leukemia: Focus on topotecan. Semin Hematol 36:16-25.
22. Khorasanizadeh S. 2004. The nucleosome: From genomic organization to genomic regulation. Cell 116:259-272.
23. Kratzmeier M, Albig W, Meergans T, Doenecke D. 1999. Changes in the protein pattern of H1 histones associated with apoptotic DNA fragmentation. Biochem J 337(Pt 2):319-327.
24. Kratzmeier M, Albig W, Haenecke K, Doenecke D. 2000. Rapid dephosphorylation of H1 histones after apoptosis induction. J Biol Chem 275:30478-30486.
25. Langan TA, Zeilig C, Leichtling B. 1981. Characterization of multiple-site phosphorylation of H1 histone in proliferating cells. Protein Phosphorylation 8:1039-1052.
26. Lee E, Nakatsuma A, Hiraoka R, Ishikawa E, Enomoto R, Yamauchi A. 1999. Involvement of histone phosphorylation in thymocyte apoptosis by protein phosphatase inhibitors. IUBMB Life 48:79-83.
27. Ling YH, Xu B. 1993. Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells. Zhongguo Yao Li Xue Bao 14:546-550.
28. Longley DB, Harkin DP, Johnston PG. 2003. 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer 3:330-338.
29. Loury R, Sassone-Corsi P. 2003. Histone phosphorylation: How to proceed. Methods 31:40-48.
30. Meergans T, Hildebrandt AK, Horak D, Haenisch C, Wendel A. 2000. The short prodomain influences caspase-3 activation in HeLa cells. Biochem J 349:135-140.
31. Mikhailov A, Shinohara M, Rieder CL. 2004. Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. J Cell Biol 166:517-526.
32. Norbury C, Blow J, Nurse P. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. Embo J 10:3321-3329.
33. Ormerod MG. 2000. Flow cytometry in the study of apoptosis. In Flow cytometry. New York: Oxford University Press, pp 235-248.
34. Pilch DR, Sedelnikova OA, Redon C, Celeste A, Nussenzweig A, Bonner WM. 2003. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem Cell Biol 81:123-129.
35. Prigent C, Dimitrov S. 2003. Phosphorylation of serine 10 in histone H3, what for? J Cell Sci 116:3677-3685.
36. Roberge M, Th'ng J, Hamaguchi J, Bradbury EM. 1990. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells. J Cell Biol 111:1753-1762.
37. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858-5868.
38. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. 2000. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 275:9390-9395.
39. Rogalinska M. 2002. Alterations in cell nuclei during apoptosis. Cell Mol Biol Lett 7:995-1018.
40. Shao RG, Cao CX, Shimizu T, O'Connor PM, Kohn KW, Pommier Y. 1997. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function. Cancer Res 57:4029-4035.
41. Shiio Y, Eisenman RN. 2003. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 100:13225-13230.
42. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403:41-45.
43. Sugiyama K, Sugiura K, Hara T, Sugimoto K, Shima H, Honda K, Furukawa K, Yamashita S, Urano T. 2002. Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene 21:3103-3111.
44. Talasz H, Helliger W, Puschendorf B, Lindner H. 1996. In vivo phosphorylation of histone H1 variants during the cell cycle. Biochemistry 35:1761-1767.
45. Talasz H, Helliger W, Sarg B, Debbage PL, Puschendorf B, Lindner H. 2002. Hyperphosphorylation of histone H2A.X and dephosphorylation of histone H1 subtypes in the course of apoptosis. Cell Death Differ 9:27-39.
46. Th'ng JP. 2001. Histone modifications and apoptosis: Cause or consequence? Biochem Cell Biol 79:305-311.
47. Thornberry NA. 1994. Interleukin-1 beta converting enzyme. Methods Enzymol 244:615-631.
48. Tsao YP, D'Arpa P, Liu LF. 1992. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: Altered regulation of p34cdc2/cyclin B. Cancer Res 52:1823-1829.
49. Wang D, Lippard SJ. 2004. Cisplatin-induced post-translational modification of histones H3 and H4. J Biol Chem 279:20622-20625.
50. Waring P, Khan T, Sjaarda A. 1997. Apoptosis induced by gliotoxin is preceded by phosphorylation of histone H3 and enhanced sensitivity of chromatin to nuclease digestion. J Biol Chem 272:17929-17936.
51. Yamada K, Itoh R. 1994. Involvement of DNA polymerase delta and/or epsilon in joining UV-induced DNA single strand breaks in human fibroblasts (comparison of effects of butylphenyldeoxyguanosine with aphidicolin). Biochim Biophys Acta 1219:302-306.